azd8566
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00749333)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd8566
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00866385 | Phase 1 | Mar 1, 2009 | AstraZeneca, Pharmaceutical Profiles |
| NCT00844103 | Phase 1 | Jan 1, 2009 | AstraZeneca |
| NCT00749333 | Phase 1 | Aug 1, 2008 | AstraZeneca, University of Nottingham |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 3 | 3 | 1 | 2008 |
| Pharmaceutical Profiles | For profit | 1 | 0 | 1 | 2009 |
| University of Nottingham | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1